Alanine aminotransferase levels as therapeutic targets after nucleotide/nucleoside analog therapy in patient with chronic hepatitis B.
Hepatology research : the official journal of the Japan Society of Hepatology(2023)
Abstract
ALT <21 IU/L at 1 year after NA initiation has a lower risk of HCC and could be used as a target value for NA treatment.
MoreTranslated text
Key words
alanine aminotransferase,hepatitis B virus,hepatocellular carcinoma,nucleoside/nucleotide analog
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined